Janssen, Novavax plan Mexican late stage COVID-19 vaccine trials, minister says

FILE PHOTO: Trailers are shown in a city parking lot after a Phase 3 trial location of Johnson & Johnson's Janssen (COVID-19) vaccine candidate was announced in National City during the outbreak of the coronavirus disease (COVID-19) in National City, California, U.S., October 13, 2020. REUTERS/Mike Blake

Johnson & Johnson's Janssen unit has received the green light to carry out late stage trials for its coronavirus vaccine in Mexico, Foreign Minister Marcelo Ebrard on Tuesday. He said U.S. vaccine developer Novavax Inc earlier this month also presented health authorities with a request to conduct phase 3 testing in Mexico.

(Reporting by Ana Isabel Martinez and Drazen Jorgic; Editing by Frank Jack Daniel)

FILE PHOTO: A Novavax logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration